NIPT (Non Invasive Prenatal Testing)
This is a first-line test globally recommended for detecting fetal abnormalities and eliminates the need for invasive methods like amniocentosis/chorionic villus sampling.
Recommended for: High-risk pregnancies, family history of aneuploidy, advanced maternal age, abnormal ultrasound.
Sample type: 9-10 ml maternal blood in cell-free DNA BCT Streck tube, at minimum 10 weeks of gestation.
Product features: Accuracy of 99% Fast TAT of 15 days Includes all trisomies and 23 pairs of chromosomes (whole fetal genome)
|Age||16-20, 21-30, 31-40, 41-50|